Editore: Elsevier March 2017, Philadelphia, 2017
ISBN 10: 0323477437 ISBN 13: 9780323477437
Da: Attic Books (ABAC, ILAB), London, ON, Canada
EUR 26,19
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. Clinics in Laboratory Medicine. xvii, 241 p. 24 cm. Colour and b&w graphs, figures, and tables. Hardcover.
Da: Chiron Media, Wallingford, Regno Unito
EUR 63,81
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: Majestic Books, Hounslow, Regno Unito
EUR 74,99
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Elsevier Science Health Science div, 2013
ISBN 10: 1455771104 ISBN 13: 9781455771103
Da: Revaluation Books, Exeter, Regno Unito
EUR 71,21
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 205 pages. 9.10x6.10x0.70 inches. In Stock.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2013
ISBN 10: 1455771104 ISBN 13: 9781455771103
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 80,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 87,21
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 86,81
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 9.10x6.00x0.80 inches. In Stock.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 82,78
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Health Sciences Jan 2013, 2013
ISBN 10: 1455771104 ISBN 13: 9781455771103
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 81,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In October of 2011, CLSI published a new guideline EP23A on 'Laboratory Quality Control Based on Risk Management.? In March, 2012, CMS announced its intention to incorporate key concepts from EP23A into its Interpretative Guidelines and QC policy for 'Individualized Quality Control Plans.? Thus begins a new era of Quality Control in the Age of Risk Management. This issue is intended to help laboratories with the transition between traditional QC practices and the new risk management approach. Laboratories face a steep learning curve to apply risk analysis for identifying and prioritizing failure-modes, developing and implementing control mechanisms to detect those failure-modes, and assessing the acceptability of the residual risks that exist after implementation of a QC Plan. One of the main benefits of the new risk analysis based QC Plans should be an integration of all the control mechanisms that are needed to monitor the total testing process, including pre-analytic, analytic, and post-analytic controls. One of the main risks of the new approach is an expectation that Statistical QC is no longer important, even though SQC still remains the most useful and flexible approach for monitoring the quality of the analytic process. The key to the future is the successful integration of all these control mechanisms to provide a cost-effective quality system that monitors all phases of the total testing process. This issue should help laboratories understand the evolution of QC practices to include risk management, but also to recognize the need to maintain traditional techniques such as Statistical QC, especially during the transition to well-designed and carefully-validated QC Plans. Risk analysis may be risky business unless laboratories proceed carefully and cautiously. 205 pp. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 93,27
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In October of 2011, CLSI published a new guideline EP23A on 'Laboratory Quality Control Based on Risk Management.? In March, 2012, CMS announced its intention to incorporate key concepts from EP23A into its Interpretative Guidelines and QC policy for 'Individualized Quality Control Plans.? Thus begins a new era of Quality Control in the Age of Risk Management. This issue is intended to help laboratories with the transition between traditional QC practices and the new risk management approach. Laboratories face a steep learning curve to apply risk analysis for identifying and prioritizing failure-modes, developing and implementing control mechanisms to detect those failure-modes, and assessing the acceptability of the residual risks that exist after implementation of a QC Plan. One of the main benefits of the new risk analysis based QC Plans should be an integration of all the control mechanisms that are needed to monitor the total testing process, including pre-analytic, analytic, and post-analytic controls. One of the main risks of the new approach is an expectation that Statistical QC is no longer important, even though SQC still remains the most useful and flexible approach for monitoring the quality of the analytic process. The key to the future is the successful integration of all these control mechanisms to provide a cost-effective quality system that monitors all phases of the total testing process. This issue should help laboratories understand the evolution of QC practices to include risk management, but also to recognize the need to maintain traditional techniques such as Statistical QC, especially during the transition to well-designed and carefully-validated QC Plans. Risk analysis may be risky business unless laboratories proceed carefully and cautiously.